Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,564 | N/A | -4,041 | -9,966 | -6,291 |
| Depreciation Amortization | 65 | N/A | 42 | 127 | 108 |
| Accounts receivable | 88 | N/A | 270 | -897 | -673 |
| Accounts payable and accrued liabilities | -1,224 | N/A | 656 | 1,597 | 30 |
| Other Working Capital | -790 | N/A | 957 | 692 | -377 |
| Other Operating Activity | -603 | 0 | -458 | 5,548 | 4,580 |
| Operating Cash Flow | $-14,028 | $N/A | $-2,574 | $-2,899 | $-2,623 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14 | N/A | N/A | 2,193 | 1,814 |
| PPE Investments | -5,413 | N/A | -2,042 | -1,300 | -69 |
| Sale Of Investment | N/A | N/A | N/A | 1,173 | 1,152 |
| Other Investing Activity | -2 | 0 | 0 | -116 | -10 |
| Investing Cash Flow | $-5,401 | $N/A | $-2,042 | $1,950 | $2,887 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,975 | N/A | N/A | 17,836 | 17,576 |
| Financing Cash Flow | $13,975 | $N/A | $N/A | $17,836 | $17,576 |
| Exchange Rate Effect | 381 | N/A | 146 | -828 | -502 |
| Beginning Cash Position | 19,681 | N/A | 20,314 | 4,530 | 4,450 |
| End Cash Position | 14,608 | N/A | 15,844 | 20,589 | 21,788 |
| Net Cash Flow | $-5,073 | $N/A | $-4,470 | $16,059 | $17,338 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,028 | N/A | -2,574 | -2,899 | -2,623 |
| Capital Expenditure | -5,413 | N/A | -2,042 | -1,300 | -69 |
| Free Cash Flow | -19,441 | 0 | -4,616 | -4,199 | -2,692 |